TP53 and adenocarcinoma: Unlike the Pten/Tp53 null mouse organoids, the adenocarcinoma LuCaPs organoids decrease proliferation in the presence of androgen receptor inhibitors (Beshiri, Agarwal, Jansson, and Kelly, unpublished).